276 related articles for article (PubMed ID: 19495757)
1. Colitis-associated cancer: the role of T cells in tumor development.
Waldner MJ; Neurath MF
Semin Immunopathol; 2009 Jul; 31(2):249-56. PubMed ID: 19495757
[TBL] [Abstract][Full Text] [Related]
2. Immunopathogenesis of Colitis-Associated Cancer in an Animal Model.
Zhao JL; Xiao CX; Guleng B
Crit Rev Eukaryot Gene Expr; 2015; 25(3):245-51. PubMed ID: 26558947
[TBL] [Abstract][Full Text] [Related]
3. Cytokines in colitis associated cancer: potential drug targets?
Waldner MJ; Neurath MF
Inflamm Allergy Drug Targets; 2008 Sep; 7(3):187-94. PubMed ID: 18782026
[TBL] [Abstract][Full Text] [Related]
4. Intestinal inflammation and colorectal cancer: a double-edged sword?
Rizzo A; Pallone F; Monteleone G; Fantini MC
World J Gastroenterol; 2011 Jul; 17(26):3092-100. PubMed ID: 21912451
[TBL] [Abstract][Full Text] [Related]
5. Potential avenues for immunotherapy of colitis-associated neoplasia.
Waldner MJ; Neurath MF
Immunotherapy; 2012 Apr; 4(4):397-405. PubMed ID: 22512634
[TBL] [Abstract][Full Text] [Related]
6. Mucosal T cell proliferation and apoptosis in inflammatory bowel disease.
Sturm A; de Souza HS; Fiocchi C
Curr Drug Targets; 2008 May; 9(5):381-7. PubMed ID: 18473766
[TBL] [Abstract][Full Text] [Related]
7. An innately dangerous balancing act: intestinal homeostasis, inflammation, and colitis-associated cancer.
Asquith M; Powrie F
J Exp Med; 2010 Aug; 207(8):1573-7. PubMed ID: 20679404
[TBL] [Abstract][Full Text] [Related]
8. The dual role of inflammation in colon carcinogenesis.
Monteleone G; Pallone F; Stolfi C
Int J Mol Sci; 2012; 13(9):11071-11084. PubMed ID: 23109839
[TBL] [Abstract][Full Text] [Related]
9. miR-301a promotes intestinal mucosal inflammation through induction of IL-17A and TNF-α in IBD.
He C; Shi Y; Wu R; Sun M; Fang L; Wu W; Liu C; Tang M; Li Z; Wang P; Cong Y; Liu Z
Gut; 2016 Dec; 65(12):1938-1950. PubMed ID: 26338824
[TBL] [Abstract][Full Text] [Related]
10. Analysis of colon-infiltrating γδ T cells in chronic inflammatory bowel disease and in colitis-associated cancer.
Lo Presti E; Mocciaro F; Mitri RD; Corsale AM; Di Simone M; Vieni S; Scibetta N; Unti E; Dieli F; Meraviglia S
J Leukoc Biol; 2020 Aug; 108(2):749-760. PubMed ID: 32202356
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms by which inflammation may increase intestinal cancer risk in inflammatory bowel disease.
O'Connor PM; Lapointe TK; Beck PL; Buret AG
Inflamm Bowel Dis; 2010 Aug; 16(8):1411-20. PubMed ID: 20155848
[TBL] [Abstract][Full Text] [Related]
12. Proinflammatory CD4+ CD45RB(hi) lymphocytes promote mammary and intestinal carcinogenesis in Apc(Min/+) mice.
Rao VP; Poutahidis T; Ge Z; Nambiar PR; Horwitz BH; Fox JG; Erdman SE
Cancer Res; 2006 Jan; 66(1):57-61. PubMed ID: 16397216
[TBL] [Abstract][Full Text] [Related]
13. Patients with inflammatory bowel disease (IBD) reveal increased induction capacity of intracellular interferon-gamma (IFN-gamma) in peripheral CD8+ lymphocytes co-cultured with intestinal epithelial cells.
Bisping G; Lügering N; Lütke-Brintrup S; Pauels HG; Schürmann G; Domschke W; Kucharzik T
Clin Exp Immunol; 2001 Jan; 123(1):15-22. PubMed ID: 11167992
[TBL] [Abstract][Full Text] [Related]
14. Inflammation and colorectal cancer.
Kraus S; Arber N
Curr Opin Pharmacol; 2009 Aug; 9(4):405-10. PubMed ID: 19589728
[TBL] [Abstract][Full Text] [Related]
15. Induced reactivity of intestinal CD4(+) T cells with an epithelial cell lectin, galectin-4, contributes to exacerbation of intestinal inflammation.
Hokama A; Mizoguchi E; Sugimoto K; Shimomura Y; Tanaka Y; Yoshida M; Rietdijk ST; de Jong YP; Snapper SB; Terhorst C; Blumberg RS; Mizoguchi A
Immunity; 2004 Jun; 20(6):681-93. PubMed ID: 15189734
[TBL] [Abstract][Full Text] [Related]
16. Antibodies against tumor necrosis factor (TNF) induce T-cell apoptosis in patients with inflammatory bowel diseases via TNF receptor 2 and intestinal CD14⁺ macrophages.
Atreya R; Zimmer M; Bartsch B; Waldner MJ; Atreya I; Neumann H; Hildner K; Hoffman A; Kiesslich R; Rink AD; Rau TT; Rose-John S; Kessler H; Schmidt J; Neurath MF
Gastroenterology; 2011 Dec; 141(6):2026-38. PubMed ID: 21875498
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive intestinal T helper cell profiling reveals specific accumulation of IFN-γ+IL-17+coproducing CD4+ T cells in active inflammatory bowel disease.
Globig AM; Hennecke N; Martin B; Seidl M; Ruf G; Hasselblatt P; Thimme R; Bengsch B
Inflamm Bowel Dis; 2014 Dec; 20(12):2321-9. PubMed ID: 25248005
[TBL] [Abstract][Full Text] [Related]
18. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
19. Microscopic Colitis Evolved Into Inflammatory Bowel Diseases Is Characterized by Increased Th1/Tc1 Cells in Colonic Mucosal Lamina Propria.
Li J; Yan Y; Meng Z; Liu S; Beck PL; Ghosh S; Qian J; Gui X
Dig Dis Sci; 2017 Oct; 62(10):2755-2767. PubMed ID: 28597107
[TBL] [Abstract][Full Text] [Related]
20. Interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) are necessary in the early stages of induction of CD4 and CD8 cytotoxic T cells by Mycobacterium leprae heat shock protein (hsp) 65 kD.
Sasiain MC; de la Barrera S; Fink S; Finiasz M; Alemán M; Fariña MH; Pizzariello G; Valdez R
Clin Exp Immunol; 1998 Nov; 114(2):196-203. PubMed ID: 9822276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
